| 000 | 01833 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513153234.0 | ||
| 264 | 0 | _c19981209 | |
| 008 | 199812s 0 0 eng d | ||
| 022 | _a8755-6863 | ||
| 024 | 7 |
_a10.1002/(sici)1099-0496(199809)26:3<155::aid-ppul1>3.0.co;2-k _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarms, H K | |
| 245 | 0 | 0 |
_aMulticenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group. _h[electronic resource] |
| 260 |
_bPediatric pulmonology _cSep 1998 |
||
| 300 |
_a155-61 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCystic Fibrosis _xdrug therapy |
| 650 | 0 | 4 |
_aDeoxyribonuclease I _xadministration & dosage |
| 650 | 0 | 4 |
_aExpectorants _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aRespiratory Function Tests |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMatouk, E | |
| 700 | 1 | _aTournier, G | |
| 700 | 1 | _avon der Hardt, H | |
| 700 | 1 | _aWeller, P H | |
| 700 | 1 | _aRomano, L | |
| 700 | 1 | _aHeijerman, H G | |
| 700 | 1 | _aFitzGerald, M X | |
| 700 | 1 | _aRichard, D | |
| 700 | 1 | _aStrandvik, B | |
| 700 | 1 | _aKolbe, J | |
| 700 | 1 | _aKraemer, R | |
| 700 | 1 | _aMichalsen, H | |
| 773 | 0 |
_tPediatric pulmonology _gvol. 26 _gno. 3 _gp. 155-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1099-0496(199809)26:3<155::aid-ppul1>3.0.co;2-k _zAvailable from publisher's website |
| 999 |
_c9738610 _d9738610 |
||